Brian Sodikoff

Brian Sodikoff

Katten Muchin Rosenman LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Patent Trial and Appeal Board Issues First IPR Decisions on Orange Book-Listed Patents

On December 9, 2014, the Patent Trial and Appeal Board (PTAB) issued final decisions in three inter partes review (IPR) proceedings filed by Amneal Pharmaceuticals challenging three patents listed in the Orange Book for...more

12/15/2014 - America Invents Act Inter Partes Review Proceedings Patent Trial and Appeal Board Pharmaceutical Pharmaceutical Manufacturers Pharmaceutical Patents

Comments Sought by December 19th on the FDA's Proposed Criteria for "First Generic" Applications

This morning, the Food and Drug Administration (FDA) opened a public docket and requested comments on its proposed criteria for expedited review of "first generic" Abbreviated New Drug Applications (ANDAs). The comment period...more

11/20/2014 - ANDA FDA Generic Drugs Hatch-Waxman Patent Infringement Patents Pharmaceutical Patents Rulemaking Process

Supreme Court Unanimously Rejects Federal Circuit Standards for Indefiniteness and Induced Infringement

The US Supreme Court issued two anticipated decisions on June 2, 2014, relating to the US Court of Appeals for the Federal Circuit's standards for indefiniteness and induced infringement. In the first, Nautilus, Inc....more

6/9/2014 - Definiteness Indefiniteness Induced Infringement Infringement Nautilus Inc. v. Biosig Instruments Patent Infringement Patent Litigation Patents SCOTUS

Enantiomer Patents: Innovative or Obvious?

I. Introduction - Stereochemistry relates to the spatial organization of atoms in a molecule. Often molecules having the same chemical makeup can exist in different spatial arrangements. These related molecules are...more

2/13/2014 - Innovation Obviousness Patent Applications Patents

4 Results
|
View per page
Page: of 1